{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:07:57Z","timestamp":1791209277006,"version":"4.1.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1038\/ncpgasthep0683","type":"journal-article","created":{"date-parts":[[2007,1,4]],"date-time":"2007-01-04T20:58:08Z","timestamp":1167944288000},"page":"24-34","source":"Crossref","is-referenced-by-count":128,"title":["Management strategies in alcoholic liver disease"],"prefix":"10.1038","volume":"4","author":[{"given":"Herbert","family":"Tilg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncpgasthep0683_CR1","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/j.1365-2036.2004.01881.x","volume":"19","author":"S Tome","year":"2004","unstructured":"Tome S and Lucey MR (2004) Review article: current management of alcoholic liver disease. Aliment Pharmacol Ther 19: 707\u2013714","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 1","key":"BFncpgasthep0683_CR2","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/S0168-8278(02)00427-0","volume":"38","author":"SF Stewart","year":"2003","unstructured":"Stewart SF and Day CP (2003) The management of alcoholic liver disease. J Hepatol 38 (Suppl 1): S2\u2013S13","journal-title":"J Hepatol"},{"key":"BFncpgasthep0683_CR3","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1172\/JCI105200","volume":"44","author":"CS Lieber","year":"1965","unstructured":"Lieber CS  et al. (1965) Effects of prolonged ethanol intake: production of fatty liver despite adequate diets. J Clin Invest 44: 1009\u20131021","journal-title":"J Clin Invest"},{"key":"BFncpgasthep0683_CR4","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1002\/hep.1840220616","volume":"22","author":"MR Teli","year":"1995","unstructured":"Teli MR  et al. (1995) The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 22: 1714\u20131719","journal-title":"Hepatology"},{"key":"BFncpgasthep0683_CR5","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1096\/fj.00-0650rev","volume":"15","author":"H Tsukamoto","year":"2001","unstructured":"Tsukamoto H and Lu SC (2001) Current concepts in the pathogenesis of alcoholic liver injury. FASEB J 15: 1335\u20131349","journal-title":"FASEB J"},{"key":"BFncpgasthep0683_CR6","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/0002-9343(68)90111-3","volume":"44","author":"WJ Powell Jr","year":"1968","unstructured":"Powell WJ Jr and Klatskin G (1968) Duration of survival in patients with Laennec's cirrhosis. Influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease. Am J Med 44: 406\u2013420","journal-title":"Am J Med"},{"key":"BFncpgasthep0683_CR7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1046\/j.1360-0443.2002.00018.x","volume":"97","author":"A Moyer","year":"2002","unstructured":"Moyer A  et al. (2002) Brief interventions for alcohol problems: a meta-analytic review of controlled investigations in treatment-seeking and non-treatment-seeking populations. Addiction 97: 279\u2013292","journal-title":"Addiction"},{"key":"BFncpgasthep0683_CR8","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1001\/jama.281.14.1318","volume":"281","author":"JC Garbutt","year":"1999","unstructured":"Garbutt JC  et al. (1999) Pharmacological treatment of alcohol dependence: a review of the evidence. JAMA 281: 1318\u20131325","journal-title":"JAMA"},{"key":"BFncpgasthep0683_CR9","first-page":"687","volume":"16","author":"T Delgrange","year":"1992","unstructured":"Delgrange T  et al. (1992) [Effect of acute administration of acamprosate on the risk of encephalopathy and on arterial pressure in patients with alcoholic cirrhosis][French]. Gastroenterol Clin Biol 16: 687\u2013691","journal-title":"Gastroenterol Clin Biol"},{"key":"BFncpgasthep0683_CR10","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1001\/jama.1986.03380110055026","volume":"256","author":"RK Fuller","year":"1986","unstructured":"Fuller RK  et al. (1986) Disulfiram treatment of alcoholism. A Veterans Administration cooperative study. JAMA 256: 1449\u20131455","journal-title":"JAMA"},{"key":"BFncpgasthep0683_CR11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","volume":"75","author":"WC Maddrey","year":"1978","unstructured":"Maddrey WC  et al. (1978) Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 75: 193\u2013199","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0683_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1055\/s-2008-1040531","volume":"8","author":"WC Maddrey","year":"1988","unstructured":"Maddrey WC (1988) Alcoholic hepatitis: clinicopathologic features and therapy. Semin Liver Dis 8: 91\u2013102","journal-title":"Semin Liver Dis"},{"key":"BFncpgasthep0683_CR13","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/0016-5085(87)90861-4","volume":"92","author":"H Orrego","year":"1987","unstructured":"Orrego H  et al. (1987) Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis. Gastroenterology 92: 208\u2013214","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0683_CR14","first-page":"210","volume":"86","author":"A Chedid","year":"1991","unstructured":"Chedid A  et al. (1991) Prognostic factors in alcoholic liver disease. VA Cooperative Study Group. Am J Gastroenterol 86: 210\u2013216","journal-title":"Am J Gastroenterol"},{"key":"BFncpgasthep0683_CR15","doi-asserted-by":"publisher","first-page":"685","DOI":"10.7326\/0003-4819-110-9-685","volume":"110","author":"RL Carithers Jr","year":"1989","unstructured":"Carithers RL Jr  et al. (1989) Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Ann Intern Med 110: 685\u2013690","journal-title":"Ann Intern Med"},{"key":"BFncpgasthep0683_CR16","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/S0168-8278(01)00289-6","volume":"36","author":"P Mathurin","year":"2002","unstructured":"Mathurin P  et al. (2002) Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH. J Hepatol 36: 480\u2013487","journal-title":"J Hepatol"},{"key":"BFncpgasthep0683_CR17","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1111\/j.1572-0241.1998.00587.x","volume":"93","author":"AJ McCullough","year":"1998","unstructured":"McCullough AJ and O'Connor JF (1998) Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology. Am J Gastroenterol 93: 2022\u20132036","journal-title":"Am J Gastroenterol"},{"key":"BFncpgasthep0683_CR18","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/00004836-200405000-00012","volume":"38","author":"K Kulkarni","year":"2004","unstructured":"Kulkarni K  et al. (2004) The role of the discriminant factor in the assessment and treatment of alcoholic hepatitis. J Clin Gastroenterol 38: 453\u2013459","journal-title":"J Clin Gastroenterol"},{"key":"BFncpgasthep0683_CR19","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.jhep.2004.02.010","volume":"40","author":"A Said","year":"2004","unstructured":"Said A  et al. (2004) Model for End Stage Liver Disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 40: 897\u2013903","journal-title":"J Hepatol"},{"key":"BFncpgasthep0683_CR20","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/hep.20503","volume":"41","author":"W Dunn","year":"2005","unstructured":"Dunn W  et al. (2005) MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology 41: 353\u2013358","journal-title":"Hepatology"},{"key":"BFncpgasthep0683_CR21","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1136\/gut.2004.050781","volume":"54","author":"EH Forrest","year":"2005","unstructured":"Forrest EH  et al. (2005) Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut 54: 1174\u20131179","journal-title":"Gut"},{"key":"BFncpgasthep0683_CR22","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/hep.1840200228","volume":"20","author":"J Hansen","year":"1994","unstructured":"Hansen J  et al. (1994) The role of tumor necrosis factor-alpha in acute endotoxin-induced hepatotoxicity in ethanol-fed rats. Hepatology 20: 461\u2013474","journal-title":"Hepatology"},{"key":"BFncpgasthep0683_CR23","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/0016-5085(95)90027-6","volume":"108","author":"Y Adachi","year":"1995","unstructured":"Adachi Y  et al. (1995) Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 108: 218\u2013224","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0683_CR24","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S0016-5085(99)70354-9","volume":"117","author":"M Yin","year":"1999","unstructured":"Yin M  et al. (1999) Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology 117: 942\u2013952","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0683_CR25","doi-asserted-by":"publisher","first-page":"G310","DOI":"10.1152\/ajpgi.00094.2004","volume":"287","author":"IN Hines","year":"2004","unstructured":"Hines IN and Wheeler MD (2004) Recent advances in alcoholic liver disease III. Role of the innate immune response in alcoholic hepatitis. Am J Physiol Gastrointest Liver Physiol 287: G310\u2013G314","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"BFncpgasthep0683_CR26","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1056\/NEJM199202203260802","volume":"326","author":"MJ Ramond","year":"1992","unstructured":"Ramond MJ  et al. (1992) A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med 326: 507\u2013512","journal-title":"N Engl J Med"},{"key":"BFncpgasthep0683_CR27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.7326\/0003-4819-113-4-299","volume":"113","author":"TF Imperiale","year":"1990","unstructured":"Imperiale TF and McCullough AJ (1990) Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials. Ann Intern Med 113: 299\u2013307","journal-title":"Ann Intern Med"},{"key":"BFncpgasthep0683_CR28","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1111\/j.1572-0241.1999.03065.x","volume":"94","author":"E Christensen","year":"1999","unstructured":"Christensen E and Gluud C (1999) Glucocorticosteroids are not effective in alcoholic hepatitis. Am J Gastroenterol 94: 3065\u20133066","journal-title":"Am J Gastroenterol"},{"key":"BFncpgasthep0683_CR29","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1053\/jhep.2003.09038","volume":"38","author":"P Mathurin","year":"2003","unstructured":"Mathurin P  et al. (2003) Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone. Hepatology 38: 1363\u20131369","journal-title":"Hepatology"},{"key":"BFncpgasthep0683_CR30","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1053\/gast.1996.v110.pm8964410","volume":"110","author":"P Mathurin","year":"1996","unstructured":"Mathurin P  et al. (1996) Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology 110: 1847\u20131853","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"BFncpgasthep0683_CR31","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1002\/hep.20957","volume":"43","author":"A Dey","year":"2006","unstructured":"Dey A and Cederbaum AI (2006) Alcohol and oxidative liver injury. Hepatology 43 (Suppl 1): S63\u2013S74","journal-title":"Hepatology"},{"issue":"Suppl ISBRA","key":"BFncpgasthep0683_CR32","doi-asserted-by":"publisher","first-page":"237S","DOI":"10.1111\/j.1530-0277.2001.tb02402.x","volume":"25","author":"AY Sun","year":"2001","unstructured":"Sun AY  et al. (2001) Ethanol and oxidative stress. Alcohol Clin Exp Res 25 (Suppl ISBRA): 237S\u2013243S","journal-title":"Alcohol Clin Exp Res"},{"key":"BFncpgasthep0683_CR33","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1056\/NEJM198209023071006","volume":"307","author":"MA Leo","year":"1982","unstructured":"Leo MA and Lieber CS (1982) Hepatic vitamin A depletion in alcoholic liver injury. N Engl J Med 307: 597\u2013601","journal-title":"N Engl J Med"},{"key":"BFncpgasthep0683_CR34","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.jhep.2005.11.039","volume":"44","author":"M Phillips","year":"2006","unstructured":"Phillips M  et al. (2006) Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis\u2014A randomised clinical trial. J Hepatol 44: 784\u2013790","journal-title":"J Hepatol"},{"key":"BFncpgasthep0683_CR35","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/0016-5085(90)90293-A","volume":"98","author":"E Cabre","year":"1990","unstructured":"Cabre E  et al. (1990) Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics. A randomized controlled trial. Gastroenterology 98: 715\u2013720","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0683_CR36","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1053\/jhep.2000.8627","volume":"32","author":"E Cabre","year":"2000","unstructured":"Cabre E  et al. (2000) Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial. Hepatology 32: 36\u201342","journal-title":"Hepatology"},{"key":"BFncpgasthep0683_CR37","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/S0006-291X(88)81271-3","volume":"155","author":"RM Strieter","year":"1988","unstructured":"Strieter RM  et al. (1988) Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline. Biochem Biophys Res Commun 155: 1230\u20131236","journal-title":"Biochem Biophys Res Commun"},{"key":"BFncpgasthep0683_CR38","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1053\/gast.2000.20189","volume":"119","author":"E Akriviadis","year":"2000","unstructured":"Akriviadis E  et al. (2000) Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 119: 1637\u20131648","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0683_CR39","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1002\/hep.510260621","volume":"26","author":"Y Iimuro","year":"1997","unstructured":"Iimuro Y  et al. (1997) Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 26: 1530\u20131537","journal-title":"Hepatology"},{"key":"BFncpgasthep0683_CR40","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1056\/NEJM200011163432007","volume":"343","author":"H Tilg","year":"2000","unstructured":"Tilg H and Diehl AM (2000) Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 343: 1467\u20131476","journal-title":"N Engl J Med"},{"key":"BFncpgasthep0683_CR41","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/S0168-8278(02)00230-1","volume":"37","author":"L Spahr","year":"2002","unstructured":"Spahr L  et al. (2002) Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study. J Hepatol 37: 448\u2013455","journal-title":"J Hepatol"},{"key":"BFncpgasthep0683_CR42","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0168-8278(02)00442-7","volume":"38","author":"H Tilg","year":"2003","unstructured":"Tilg H  et al. (2003) Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis. J Hepatol 38: 419\u2013425","journal-title":"J Hepatol"},{"key":"BFncpgasthep0683_CR43","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1002\/hep.20206","volume":"39","author":"S Naveau","year":"2004","unstructured":"Naveau S  et al. (2004) A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis. Hepatology 39: 1390\u20131397","journal-title":"Hepatology"},{"key":"BFncpgasthep0683_CR44","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1136\/gut.52.8.1182","volume":"52","author":"RP Mookerjee","year":"2003","unstructured":"Mookerjee RP  et al. (2003) Tumour necrosis factor alpha is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis. Gut 52: 1182\u20131187","journal-title":"Gut"},{"key":"BFncpgasthep0683_CR45","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/qjmed\/86.10.649","volume":"86","author":"DJ Mutimer","year":"1993","unstructured":"Mutimer DJ  et al. (1993) Managing severe alcoholic hepatitis complicated by renal failure. Q J Med 86: 649\u2013656","journal-title":"Q J Med"},{"key":"BFncpgasthep0683_CR46","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1053\/jhep.2002.35819","volume":"36","author":"R Ortega","year":"2002","unstructured":"Ortega R  et al. (2002) Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology 36: 941\u2013948","journal-title":"Hepatology"},{"key":"BFncpgasthep0683_CR47","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1056\/NEJM198712033172301","volume":"317","author":"H Orrego","year":"1987","unstructured":"Orrego H  et al. (1987) Long-term treatment of alcoholic liver disease with propylthiouracil. N Engl J Med 317: 1421\u20131427","journal-title":"N Engl J Med"},{"key":"BFncpgasthep0683_CR48","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1073\/pnas.69.4.892","volume":"69","author":"RF Diegelmann","year":"1972","unstructured":"Diegelmann RF and Peterkofsky B (1972) Inhibition of collagen secretion from bone and cultured fibroblasts by microtubular disruptive drugs. Proc Natl Acad Sci USA 69: 892\u2013896","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncpgasthep0683_CR49","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/0016-5085(79)90018-0","volume":"77","author":"D Kershenobich","year":"1979","unstructured":"Kershenobich D  et al. (1979) Treatment of cirrhosis with colchicine. A double-blind randomized trial. Gastroenterology 77: 532\u2013536","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0683_CR50","volume-title":"The Cochrane Database of Systematic Reviews","author":"A Rambaldi","year":"2001","unstructured":"Rambaldi A and Gluud C (2001) Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis. The Cochrane Database of Systematic Reviews, Issue 1, Art. No CD002148."},{"key":"BFncpgasthep0683_CR51","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1053\/j.gastro.2005.01.057","volume":"128","author":"TR Morgan","year":"2005","unstructured":"Morgan TR  et al. (2005) Colchicine treatment of alcoholic cirrhosis: a randomized, placebo-controlled clinical trial of patient survival. Gastroenterology 128: 882\u2013890","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0683_CR52","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0168-8278(89)90083-4","volume":"9","author":"P Ferenci","year":"1989","unstructured":"Ferenci P  et al. (1989) Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J Hepatol 9: 105\u2013113","journal-title":"J Hepatol"},{"key":"BFncpgasthep0683_CR53","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S0168-8278(98)80285-7","volume":"28","author":"A Pares","year":"1998","unstructured":"Pares A  et al. (1998) Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial. J Hepatol 28: 615\u2013621","journal-title":"J Hepatol"},{"key":"BFncpgasthep0683_CR54","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/S0168-8278(99)80263-3","volume":"30","author":"JM Mato","year":"1999","unstructured":"Mato JM  et al. (1999) S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. J Hepatol 30: 1081\u20131089","journal-title":"J Hepatol"},{"key":"BFncpgasthep0683_CR55","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S0016-5085(94)95023-7","volume":"106","author":"CS Lieber","year":"1994","unstructured":"Lieber CS  et al. (1994) Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon. Gastroenterology 106: 152\u2013159","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0683_CR56","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1097\/01.ALC.0000093743.03049.80","volume":"27","author":"CS Lieber","year":"2003","unstructured":"Lieber CS  et al. (2003) II. Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease. Alcohol Clin Exp Res 27: 1765\u20131772","journal-title":"Alcohol Clin Exp Res"},{"key":"BFncpgasthep0683_CR57","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/bmj.301.6742.15","volume":"301","author":"GL Bird","year":"1990","unstructured":"Bird GL  et al. (1990) Liver transplantation in patients with alcoholic cirrhosis: selection criteria and rates of survival and relapse. BMJ 301: 15\u201317","journal-title":"BMJ"},{"key":"BFncpgasthep0683_CR58","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S0168-8278(01)00278-1","volume":"36","author":"J Neuberger","year":"2002","unstructured":"Neuberger J  et al. (2002) Transplantation for alcoholic liver disease. J Hepatol 36: 130\u2013137","journal-title":"J Hepatol"},{"key":"BFncpgasthep0683_CR59","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/lt.500030307","volume":"3","author":"RH Wiesner","year":"1997","unstructured":"Wiesner RH  et al. (1997) Liver transplantation for end-stage alcoholic liver disease: an assessment of outcomes. Liver Transpl Surg 3: 231\u2013239","journal-title":"Liver Transpl Surg"},{"key":"BFncpgasthep0683_CR60","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/S0140-6736(94)91897-X","volume":"344","author":"T Poynard","year":"1994","unstructured":"Poynard T  et al. (1994) Evaluation of efficacy of liver transplantation in alcoholic cirrhosis by a case\u2013control study and simulated controls. Lancet 344: 502\u2013507","journal-title":"Lancet"},{"key":"BFncpgasthep0683_CR61","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/hep.1840110202","volume":"11","author":"S Kumar","year":"1990","unstructured":"Kumar S  et al. (1990) Orthotopic liver transplantation for alcoholic liver disease. Hepatology 11: 159\u2013164","journal-title":"Hepatology"},{"key":"BFncpgasthep0683_CR62","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1136\/gut.45.3.421","volume":"45","author":"GP Pageaux","year":"1999","unstructured":"Pageaux GP  et al. (1999) Alcoholic cirrhosis is a good indication for liver transplantation, even for cases of recidivism. Gut 45: 421\u2013426","journal-title":"Gut"},{"key":"BFncpgasthep0683_CR63","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/lt.20386","volume":"11","author":"A Cuadrado","year":"2005","unstructured":"Cuadrado A  et al. (2005) Alcohol recidivism impairs long-term patient survival after orthotopic liver transplantation for alcoholic liver disease. Liver Transpl 11: 420\u2013426","journal-title":"Liver Transpl"},{"key":"BFncpgasthep0683_CR64","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1176\/appi.psy.42.2.110","volume":"42","author":"RM Weinrieb","year":"2001","unstructured":"Weinrieb RM  et al. (2001) Alcoholism treatment after liver transplantation: lessons learned from a clinical trial that failed. Psychosomatics 42: 110\u2013116","journal-title":"Psychosomatics"},{"key":"BFncpgasthep0683_CR65","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1136\/bmj.317.7152.172","volume":"317","author":"J Neuberger","year":"1998","unstructured":"Neuberger J  et al. (1998) Assessing priorities for allocation of donor liver grafts: survey of public and clinicians. BMJ 317: 172\u2013175","journal-title":"BMJ"},{"key":"BFncpgasthep0683_CR66","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/hep.510250628","volume":"25","author":"AC Anand","year":"1997","unstructured":"Anand AC  et al. (1997) Liver transplantation for alcoholic liver disease: evaluation of a selection protocol. Hepatology 25: 1478\u20131484","journal-title":"Hepatology"},{"key":"BFncpgasthep0683_CR67","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/S0399-8320(04)95146-9","volume":"28","author":"M Miguet","year":"2004","unstructured":"Miguet M  et al. (2004) Predictive factors of alcohol relapse after orthotopic liver transplantation for alcoholic liver disease. Gastroenterol Clin Biol 28: 845\u2013851","journal-title":"Gastroenterol Clin Biol"},{"key":"BFncpgasthep0683_CR68","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1002\/hep.510250627","volume":"25","author":"PF Foster","year":"1997","unstructured":"Foster PF  et al. (1997) Prediction of abstinence from ethanol in alcoholic recipients following liver transplantation. Hepatology 25: 1469\u20131477","journal-title":"Hepatology"},{"key":"BFncpgasthep0683_CR69","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0168-8278(01)00228-8","volume":"36","author":"BJ Veldt","year":"2002","unstructured":"Veldt BJ  et al. (2002) Indication of liver transplantation in severe alcoholic liver cirrhosis: quantitative evaluation and optimal timing. J Hepatol 36: 93\u201398","journal-title":"J Hepatol"},{"key":"BFncpgasthep0683_CR70","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S0168-8278(02)00086-7","volume":"36","author":"MR Lucey","year":"2002","unstructured":"Lucey MR (2002) Is liver transplantation an appropriate treatment for acute alcoholic hepatitis? J Hepatol 36: 829\u2013831","journal-title":"J Hepatol"},{"key":"BFncpgasthep0683_CR71","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/lt.20688","volume":"12","author":"A DiMartini","year":"2006","unstructured":"DiMartini A  et al. (2006) Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease. Liver Transpl 12: 813\u2013820","journal-title":"Liver Transpl"},{"key":"BFncpgasthep0683_CR72","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S0168-8278(02)00047-8","volume":"36","author":"S Tome","year":"2002","unstructured":"Tome S  et al. (2002) Influence of superimposed alcoholic hepatitis on the outcome of liver transplantation for end-stage alcoholic liver disease. J Hepatol 36: 793\u2013798","journal-title":"J Hepatol"}],"container-title":["Nature Clinical Practice Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpgasthep0683.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpgasthep0683","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpgasthep0683.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:04:43Z","timestamp":1684440283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpgasthep0683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["BFncpgasthep0683"],"URL":"https:\/\/doi.org\/10.1038\/ncpgasthep0683","relation":{},"ISSN":["1743-4378","1743-4386"],"issn-type":[{"value":"1743-4378","type":"print"},{"value":"1743-4386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}